Glanzmann Thrombasthenia Follow-up

Updated: Dec 29, 2017
  • Author: Zonera Ashraf Ali, MBBS; Chief Editor: Srikanth Nagalla, MBBS, MS, FACP  more...
  • Print
Follow-up

Deterrence/Prevention

Patients with Glanzmann thrombasthenia should avoid drugs that decrease platelet function or coagulation, such as the following:

  • Aspirin or other NSAIDs

  • Heparin

  • Warfarin

  • Ticlopidine or clopidogrel

  • Glycoprotein IIb/IIIa antagonists, such as abciximab

  • Streptokinase, urokinase, or tissue plasminogen activator (tPA)

  • Volume expanders, such as dextran or hydroxyethyl starch

  • Dipyridamole

Next:

Prognosis

With platelet transfusions for bleeding complications, patients with Glanzmann thrombasthenia generally have a good prognosis.

Previous
Next:

Patient Education

Educate patients with Glanzmann thrombasthenia that regular dental care is necessary to avoid gingivitis and gingival bleeding.

Previous